Recommended

#BitcoinOnBTCC ：Celebrate 2024's Crypto Triumphs with Us, Every Day.
Crypto Deposit Make instant crypto transfers to your futures account
USDT-M Perpetual Futures Trade futures contracts settled in USDT
VIP Fee Discounts Enjoy different fee discounts based on your VIP level
Coin-M Perpetual Futures Trade futures contracts settled in cryptocurrency
Fiat Deposit Buy your favourite coins in seconds
Affiliates Invite friends & get rewarded
Convert Covert your crypto instantly
Support Centre Find our FAQs here
Announcements Find all our official announcements
BTCC Academy Learn about blockchain and crypto
News The latest trends in the crypto market

Promotions

Referral
Campaigns
Assets
Crypto Deposit
Fiat Deposit
Convert
Transfer
Withdraw
My vouchers
Fund history
Dashboard
Account Security
Identity verification
API Management
Transaction Report
Log out
Register
Report post
bristol myers news pepe unchain Bnb Eth XRP crypto futures coinbase futures binance futures

When will Bristol Myers Squibb (BMY) report Q2 2024 results?

Bristol Myers Squibb (NYSE: BMY) is scheduled to report its Q2 2024 results on Friday, July 26. We expect BMY stock to trade higher, with its revenue and earnings likely exceeding the street estimates. The company should benefit from continued market share gains for its growth portfolio drugs, including Reblozyl, Breyanzi, and Orencia.

What will Bristol Myers' earnings look like this year?

Bristol Myers said it now expects full-year earnings of 60 to 90 cents a share, up from its previous estimate of 40 to 70 cents a share. Analysts had forecast full-year earnings of 51 cents a share. The company's shares closed at $45.27 on Thursday, down around 14% so far this year.

Which Bristol Myers drugs have a 7% increase in sales?

Of Bristol Myers' existing drugs, Eliquis saw a 7% increase in sales year-over-year. Cancer drug Opdivo and blood cancer treatment Revlimid also saw promising results and beat quarterly sales estimates. However, those three top-performers have patents set to run out in the next few years.

Related articles

The World's Leading Crypto Trading Platform

Get my welcome gifts

Exchange for a better future

Products
Services
Guides
About Us
Terms & Agreement
Customer Service
Social Media

Risk warning: Digital asset trading is an emerging industry with bright prospects, but it also comes with huge risks as it is a new market. The risk is especially high in leveraged trading since leverage magnifies profits and amplifies risks at the same time. Please make sure you have a thorough understanding of the industry, the leveraged trading models, and the rules of trading before opening a position. Additionally, we strongly recommend that you identify your risk tolerance and only accept the risks you are willing to take. All trading involves risks, so you must be cautious when entering the market.

The world’s longest-running cryptocurrency exchange since 2011 © 2011 - 2024 BTCC.com. All rights reserved